TXNIP and neoplasm: In pancreatic cancer, the tumor suppressor FBW7 (F-box and WD Repeat Domain-Containing 7) exerts its antitumor effects by controlling glucose metabolism and oxygen consumption in a TXNIP-dependent manner [123].